Last reviewed · How we verify
Doxorubicin Induced Cardiomyopathy
Approved treatments
- Razoxin
Razoxin works by chelating iron and preventing the formation of free radicals that damage heart tissue. - Zinecard · Pfizer
Zinecard works by binding to metal ions and preventing them from causing damage to DNA during anthracycline treatment. - Zinecard · M.D. Anderson Cancer Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Doxorubicin Induced Cardiomyopathy patent landscape — cliff calendar, originator estates, attackable patents
- Doxorubicin Induced Cardiomyopathy treatment landscape brief
- Doxorubicin Induced Cardiomyopathy treatment updates RSS
Frequently asked questions about Doxorubicin Induced Cardiomyopathy
What drugs treat Doxorubicin Induced Cardiomyopathy?
Tracked treatments include Razoxin, Zinecard.
What is the treatment for Doxorubicin Induced Cardiomyopathy?
Standard treatment for Doxorubicin Induced Cardiomyopathy includes Razoxin, Zinecard. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Doxorubicin Induced Cardiomyopathy patent cliff · Doxorubicin Induced Cardiomyopathy CI report
- Treatment: Razoxin
- Treatment: Zinecard · Pfizer
- Treatment: Zinecard · M.D. Anderson Cancer Center
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing